Tower Cancer Research Foundation is a clinical research site located in Beverly Hills, California, United States 90211.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Tower Cancer Research Foundation has participated in 99 clinical trials with 42 currently active.
Therapeutic areas: Lung Cancer, Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma.
Sponsors: Proacta, Incorporated, National Cancer Institute (NCI), Celgene Corporation.
Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Tower Cancer Research Foundation has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tower Cancer Research Foundation has 99 clinical trials on record, with 42 currently active. Their work covers Lung Cancer, Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma.
Yes — Tower Cancer Research Foundation holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.